Vagus Nerve Stimulation for Myelopathy (NCT07660250)
Vagus Nerve Stimulation to Improve Post-operative Outcomes of Degenerative Cervical Myelopathy
🩺 Plain-English Summary (8th-Grade Level)
The objective of this study is to generate preliminary data to establish the feasibility and effectiveness of transauricular vagus nerve stimulation (taVNS) to improve post-operative outcomes of moderate to severe degenerative cervical myelopathy (DCM)
Who can join: Review the eligibility criteria below.
Location: Washington University — St Louis, Missouri
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Washington University — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (314) 362-7368
Email: koesterl@wustl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Degenerative Cervical Myelopathy
- Stimulation-based Therapy to Improve Balance in DCM — Milwaukee, Wisconsin
Explore by condition: All Degenerative Cervical Myelopathy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.